S&P 500

5.304,72

0,70%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Repligen Corp (RGEN)
Repligen Corp (RGEN) Notícias

RGEN

Repligen (RGEN)

Repligen Corp

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:RGEN

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
22/05/2024	18:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RGEN	Repligen Corp
22/05/2024	08:30	GlobeNewswire Inc.	Repligen Corporation to Present at Upcoming June Investor Conferences	NASDAQ:RGEN	Repligen Corp
21/05/2024	17:09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RGEN	Repligen Corp
17/05/2024	09:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RGEN	Repligen Corp
07/05/2024	08:30	GlobeNewswire Inc.	Repligen Corporation to Present at Upcoming May Investor Conferences	NASDAQ:RGEN	Repligen Corp
01/05/2024	08:30	GlobeNewswire Inc.	Repligen Reports First Quarter 2024 Financial Results	NASDAQ:RGEN	Repligen Corp
17/04/2024	08:30	GlobeNewswire Inc.	Repligen to Report First Quarter 2024 Financial Results	NASDAQ:RGEN	Repligen Corp
19/03/2024	08:30	GlobeNewswire Inc.	Repligen Appoints Maggie A. Pax to Board of Directors	NASDAQ:RGEN	Repligen Corp
22/02/2024	18:26	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RGEN	Repligen Corp
21/02/2024	09:30	GlobeNewswire Inc.	Repligen Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:RGEN	Repligen Corp
07/02/2024	09:30	GlobeNewswire Inc.	Repligen to Report Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:RGEN	Repligen Corp
06/02/2024	15:41	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RGEN	Repligen Corp
19/12/2023	09:30	GlobeNewswire Inc.	Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:RGEN	Repligen Corp
15/12/2023	21:04	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:RGEN	Repligen Corp
07/12/2023	09:30	GlobeNewswire Inc.	Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements	NASDAQ:RGEN	Repligen Corp
14/11/2023	16:01	GlobeNewswire Inc.	UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report	NASDAQ:RGEN	Repligen Corp
14/11/2023	09:30	GlobeNewswire Inc.	Repligen Announces Publication of the Company’s 2022 Sustainability Report	NASDAQ:RGEN	Repligen Corp
07/11/2023	09:30	GlobeNewswire Inc.	Repligen Corporation to Present at Upcoming Investor Conferences	NASDAQ:RGEN	Repligen Corp
02/11/2023	08:30	GlobeNewswire Inc.	Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device	NASDAQ:RGEN	Repligen Corp
31/10/2023	17:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RGEN	Repligen Corp
31/10/2023	08:30	GlobeNewswire Inc.	Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance	NASDAQ:RGEN	Repligen Corp
17/10/2023	08:30	GlobeNewswire Inc.	Repligen to Report Third Quarter 2023 Financial Results	NASDAQ:RGEN	Repligen Corp
03/10/2023	21:03	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RGEN	Repligen Corp
02/10/2023	08:30	GlobeNewswire Inc.	Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer	NASDAQ:RGEN	Repligen Corp
26/09/2023	08:30	GlobeNewswire Inc.	Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova	NASDAQ:RGEN	Repligen Corp
12/09/2023	08:30	GlobeNewswire Inc.	Repligen Appoints Jason K. Garland as Chief Financial Officer	NASDAQ:RGEN	Repligen Corp
01/09/2023	08:30	GlobeNewswire Inc.	Repligen Corporation to Present at Wells Fargo Healthcare Conference	NASDAQ:RGEN	Repligen Corp
17/08/2023	09:00	GlobeNewswire Inc.	Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification	NASDAQ:RGEN	Repligen Corp
02/08/2023	08:30	GlobeNewswire Inc.	Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance	NASDAQ:RGEN	Repligen Corp
19/07/2023	08:30	GlobeNewswire Inc.	Repligen to Report Second Quarter 2023 Financial Results	NASDAQ:RGEN	Repligen Corp